Topics
News
CME/CE
Editorial Advisory Board
Partnerships
- Dry Cracked Skin
- Impetigo
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Surgery
- Melasma
- NP and PA
- Anti-Aging
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Inflamed Skin
The Changing Faces of Acne : Episode 22
Expert Perspective on the Utilization of Clascoterone Cream 1%
Hilary Baldwin, MD, provides a recap of a panel discussion surrounding the optimal use of Clascoterone cream 1%, highlighting the ubiquity of this treatment.
EP: 1.Expert Perspectives on a Recent Approval in Acne Management
EP: 2.Treatment Selection Considerations for Mild to Moderate Acne
EP: 3.Unmet Needs and the Role of Consensus Guidelines in Acne Management
EP: 4.Future Directions and Practice Pearls for the Management of Acne
EP: 5.Expert Perspective on Tailoring Acne Treatments
EP: 6.Skin Care Regimens for Acne Treatment
EP: 7.Acne Treatment Selection Considerations
EP: 8.Overview of Isotretinoin Use and Indication in Acne Management
EP: 9.Expert Perspective on Available Isotretinoin Formulations
EP: 10.Expert Recommendations for Setting and Managing Acne Treatment Goals with Patients
EP: 11.Overview of Acne Causes and Triggers
EP: 12.Considerations for Generic vs Brand Acne Treatment Formulations
EP: 13.Expert Perspectives on Acne Causes and Triggers
EP: 14.Overview of Isotretinoin MOA and Utilization
EP: 15.Frontline Forum Part 1: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies
EP: 16.Frontline Forum Part 2: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies
EP: 17.Frontline Forum Part 3: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies
EP: 18.Frontline Forum Part 4: A Discussion of the Pathophysiology of Acne and Available Treatment Strategies
EP: 19.Expert Perspective on the Management of Acne
EP: 20.Treatment Selection in Patients with Acne Vulgaris
EP: 21.Differences in Isotretinoin Formulation
Now Viewing
EP: 22.Expert Perspective on the Utilization of Clascoterone Cream 1%
EP: 23.Utilization of Isotretinoin in Patients with Severe Acne
EP: 24.Expert Insights into the Safety of Isotretinoin
EP: 25.Overview and Prevalence of Acne Vulgaris
EP: 26.Approaches to Target Sebum Production
EP: 27.Expert Insights into the Use of Isotretinoin
EP: 28.Advances in Acne Management
EP: 29.Expert Opinion on the Utility of Guidelines in Patient Care
EP: 30.Novel Approach to Sebum Production
EP: 31.Expert Insights into the Importance of Active Components in Acne Treatments
EP: 32.Frontline Forum Part 1: A Greater Understanding of the Acne Vulgaris Armamentarium
EP: 33.Frontline Forum Part 2: A Greater Understanding of the Acne Vulgaris Armamentarium
EP: 34.Frontline Forum Part 3: A Greater Understanding of the Acne Vulgaris Armamentarium
EP: 35.Frontline Forum Part 4: A Greater Understanding of the Acne Vulgaris Armamentarium
EP: 36.Discovering Dermatology Times: August 2023 Acne Vulgaris Supplement
EP: 37.Top 5 Clinical Pearls for Acne Vulgaris Management
Related Videos
Related Content
